6-(1-Hydroxyethyl)-2-SR8-1-methyl-1-carbadethiapen-2-em-3-carboxylic acid esters
    13.
    发明公开
    6-(1-Hydroxyethyl)-2-SR8-1-methyl-1-carbadethiapen-2-em-3-carboxylic acid esters 失效
    6-(1-羟乙基)-2-SR8-1-甲基-1-十八碳烯二氧-2-烯-3-羧酸酯

    公开(公告)号:EP0113101A1

    公开(公告)日:1984-07-11

    申请号:EP83112827.7

    申请日:1983-12-20

    申请人: Merck & Co., Inc.

    IPC分类号: C07D487/04 A61K31/40

    摘要: Diselosed are 6-[1-hydroxyethyl)-2-SR 5 -1-methyl-1-carbadethiapen-2-em-3-carboxylic acid esters (I) which are oralfy active antibiotics:
    wherein: R is a pharmaceutically acceptable ester moiety consistent with oral delivery; and R' is substituted or unsubstituted: alkyl, alkenyl, alkynyl, or cyclic alkyl, alkenyl, alkynyl, having 1-6 carbon atoms, aryl such as phenyl or heteroaryl such as pyridyl; wherein the substituent or substituents are selected from: phenyl, pyridyl, cyano, fluoro, chloro, hydroxy, alkylthio such as methylthio, arylthio such as phenylthio, methoxy, phenoxy, alkoxycarbonyl such as methoxycarbonyl, acetoxyl, N-methylcarbamoyl, N-methylcarbamoyloxy and N-acylamino.
    Also disclosed are processes for the preparation of such compounds and pharmaceutical compositions comprising such compounds.

    摘要翻译: 透析的是口服活性抗生素的6- [1-羟基乙基)-2-SR5-1-甲基-1-十八碳烯二烯-2-烯-3-羧酸酯(I):其中:R是药学上可接受的酯部分一致的 口服给药; 和R'是取代或未取代的:具有1-6个碳原子的烷基,烯基,炔基或环状烷基,烯基,炔基,芳基如苯基或杂芳基如吡啶基; 其中取代基选自:苯基,吡啶基,氰基,氟,氯,羟基,烷硫基如甲硫基,芳硫基如苯硫基,甲氧基,苯氧基,烷氧基羰基如甲氧基羰基, N-酰基。 还公开了用于制备这样的化合物的方法和包含这些化合物的药物组合物。